260 mg Paclitaxel Injection IP is a highly effective agent, suited for the effective treatment of breast cancer. It can be taken as a single agent medicate. Also, it is useful in combination regimens. It has its primary use in salvage therapy and first-line therapy. Paclitax 260 MG Injection is popular as a highly popular anticancer agent, suited for the treatment of various cancers of the female reproductive system, lungs, and breast. Provided medicate should be taken under the supervision of an eligible physician. During the administration of this injection, close monitoring of blood cell count is needed.